Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
June 13 2024 - 4:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to host a business
update and analyst event during the American Diabetes Association’s
84th Scientific Sessions in Orlando, FL.
Breakfast and refreshments will be provided beginning at 9:15 am
ET on Sunday, June 23, 2024, in advance of a business update
presentation from management scheduled to begin, at 10:00 am ET.
Interested parties may access a live and recorded webcast of the
presentation on the “Investor Relations” section of the company’s
website at www.senseonics.com.
In-person attendance for the event requires advanced
registration. Please email Hannah Jeffrey at hannah@gilmartinir.com
by June 21, 2024, to register.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics’ CGM system Eversense® E3
includes a small sensor inserted completely under the skin that
communicates with a smart transmitter worn over the sensor. The
glucose data are automatically sent every 5 minutes to a mobile app
on the user’s smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240613143680/en/
Senseonics Investor Contact Philip Taylor Gilmartin Group
415-937-5406 Investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Oct 2023 to Oct 2024